PR just in.. " Impressive results continue from
Post# of 148175
" Impressive results continue from CytoDyn's Clinical trial evaluating two patients with Leronlimab, one in mTNBC and one in MBC "
Patient # 1 CTC is zero in 15 weeks.
Patient # 2 ( M-i-L)..50% shrinking of primary tumor and no signs of metastasis in the brain after treatment with Leronlimab as a...MONOTHERAPY !!!!!!
PLEASE notice MONOTHERAPY.....